Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulaglutide for Menstrual Irregularities in Adolescent Females With Type 1 Diabetes
NCT07319286Phase 2Enrolling by invitation
- Sponsor
- Ain Shams University
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of dulaglutide biosimilar 14028 injection in Menstrual irregularities, sponsored by Ain Shams University. Started Aug 2025; status: enrolling by invitation.
02
Drugs
dulaglutide biosimilar 14028 injection
03
Conditions
Menstrual irregularities
Beyond the preview
Go deeper on NCT07319286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07319286.